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Kingella kingae is a Gram-negative coccobacilli and it is a member 
of the HACEK (Haemophilus species, Aggregatibacter actinomycete-
mcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kin-
gella kingae) group. HACEK organisms are typically oropharyngeal 
commensals and have long been recognized as a cause of infective 
endocarditis in children and adults. K. kingae in difficult to recover 
from cultured pharyngeal samples due to its slow growth and the 
high presence of resident bacterial flora. However, the organism can 
be better detected using PCR tests. Based on our literature in PubMed 
and other sources, we couldn't discover any study about K. kingae 
originated in an Arab country. Therefore, we prepared this review in 
order to draw attention of our physicians and clinical microbiologists 
to the importance of this neglected group of organisms in clinical me-
dicine. This review article aims to cover the most important features 
of K. kingae in the pediatric population.
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Introduction
This review will present and discuss the most important issues about 
the opportunistic Kingella kingae. This organism is not commonly de-
tected and reported as causative agent of certain serious pediatric 
diseases in young children especially in the Arab region. The etiology 
of this organism has been only in recent years investigated and the 
pathogenesis and clinical presentation described [1-2] 
Classification of Kingella kingae
The genus Kingella is part of the Neisseriaceae family [3-4], and re-
presented by four recognized species as follow: 
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1.   Kingella kingae is a common opportunis-
tic pathogen found in oropharynx of in-
fants and young children aged between 6 
months and 5 years [3-4]. It can cause in-
vasive pediatric infections associated with 
bacteremia, osteoarticular disease, endo-
carditis pneumonia, and meningitis [4-5].
2.   K. denitrificans is a rare and opportunistic 
cause of bacteremia, endocarditis, pleura-
lempyema, pediatricvaginitis, chorioamnio-
nitis, and granulomatous disease in AIDS 
patients [6-8].
3.   K. oralis is a commensal often found in the 
human buccal cavity and is associated with 
dental plaque and periodontitis [9].
4.   K. potus is a zoonotic organism recovered 
from infected bites of animals [10].
The genome of Kingella kingae
Investigation the genomes of K. kingae isolates from 
asymptomatic carriers and patients with different 
invasive infections as well as diverse geographic ori-
gins has shown that the organism is genetically clo-
se to the other members of the Neisseriaceae family. 
K. kingae is naturally competent for the acquisition 
of DNA from other related organisms by horizontal 
gene transfer [11].
Virulence factors of Kingella kingae
The following virulence factors have been identified 
in Kingella kingae: 
A.  All invasive K. kingae isolates secrete a so-
luble RTX exotoxin that is cytotoxic against 
a broad-range of host cells, including res-
piratory epithelial cells, synovial cells, and 
macrophage cell lines. This toxin is absent 
in the less virulent species K. oralis and K. 
denitrificans [12]. The RTX exotoxin is a ma-
jor virulence factor that allows K. kingae to 
cause damage in the respiratory tract and 
joint tissues [12]. It has been shown that 
K. kingae RTX toxin is a 100-kDa protein 
which is released in the extra cellular envi-
ronment as a component of outer membra-
ne vesicles (OMVs) that are internalized by 
host cells [13]. Additionally, RTX toxin ap-
pears universally presented in K. kingae in 
order to enhance colonization fitness of the 
bacterial cells by disrupting the oropharyn-
geal epithelium. RTX toxin may also allow 
survival of K. kingae in the blood stream 
and invasion of the skeletal system tissues 
[4, 12].
B.  The virulence factor IV pili is essential for 
initial bacterial adherence to surfaces and 
enhances colonization of human epithelial 
surfaces, and tissues of the mucosa of the 
respiratory tract epithelium and synovial layer 
[12]. The expression of IV pili in K. kingae 
appears to be controlled by three genes (the 
Q-54gene, pilS, and pilR) [12].
C.  The polysaccharide capsule is an essential 
factor in bacterial adherence and the patho-
genic potential of K. kingae as it has been 
found closely related to that of N. meningi-
tidis [14]. Its capsule appears to protect the 
organism from the host immune response 
and to enhance mucosal colonization, survi-
val in the bloodstream, and invasion of deep 
body sites [14].
D.  Exopolysaccharides and biofilm formation 
are important virulence factors in adhesion 
of many bacterial pathogens, including K. 
kingae to human body surfaces. Bendaoud 
et al. [15], have shown that K. kingae strain 
PYKK181 synthesizes an exopolysaccharide 
composed of linear galactan homopolymer, 
which acts as a biofilm formation tool. It 
is well known that biofilms play a critical 
function in bacterial adherence and coloni-
zation and prevent host defence mechanisms 
in diseases such as chronic osteomyelitis and 
lung cystic fibrosis [12, 16].
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Laboratory diagnosis of Kingella kingae
Culture and identification
Kingella kingae is a Gram-negative bacterium that 
classified within the Neisseriaceae family. It is a fa-
cultative anaerobic, β-hemolytic, small bacillus (0.6 
to 1 µm x 1 to 3 µm in size), non-motile and non-
spore-forming that appears as cell pairs or short 
chains with tapered ends, often resists decoloni-
zation, and can be also misidentified as a Gram-
positive bacteria [5].
Important biochemical reactions of K. kingae 
including the following: Production of acid from 
glucose and maltose, and is oxidase-positive and 
catalase-, urease-, and indole-negative, while the 
organism is positive to alkaline and acid phosphata-
se tests [5]. Generally, it is not easily to detect K. kin-
gae in cultured pharyngeal samples due to its slow 
growth and the high density of normal pharyngeal 
bacterial flora. Therefore, it is important to culture 
such samples on a selective blood agar containing 
2 μg/ml of vancomycin (BAV medium) to inhibit the 
growth of other bacteria [3, 5]. 
The identification of K. kingae can be achieved 
by using commercial systems in the clinical micro-
biology laboratory such as API NH card and Vitek 2 
instrument [5, 17], matrix-assisted laser desorption 
ionization-time of light mass spectrometry (MALDI-
TOF), and 16S rRNA gene sequencing, but the or-
ganism can be misidentified by the Remel RapID 
NH kit [17] according to a recent still unpublished 
study (Malak A. Khanfar, MSc. Thesis, The Jordan 
University, 2019).
Molecular detection of Kingella kingae
In recent years, molecular detection methods have 
been widely and successfully used for diagnosis of 
all K. kingae infections, because the recovery of 
this organism from oropharyngeal swabs or body 
fluids is extremely difficult by using culture media. 
Among those methods, specific Real-time quanti-
tative polymerase chain reaction (qPCR) assays tar-
geting K. kingae was reported to reach sensitivity 
of up to 100% when used in optimal conditions 
[18]. Although recent studies have confirmed that 
targeting the groELgene from K. kingae is a use-
ful molecular detection assay of this organism in 
clinical specimens [19, 20]. Additionally, real-time 
assays that amplify K. kingae’s cpn60 or RTX toxin 
encoding genes is the best method for diagnosis its 
invasive infection [21] as shown in Table 1.
A recent study of EL Houmani, et al. [18] reported 
the development of K. kingae-specific RT-PCR as-
say targeting the malate dehydrogenase (mdh) gene 
including 18 variants of the K. kingae mdh gene 
obtained from 20 distinct sequence types. This new 
RT-PCR assay demonstrated high specificity and 
sensitivity and was successfully used to diagnose K. 
kingae infections. 
Several studies demonstrated that the use of K. 
kingae-specific PCR assays rises the diagnostic yield 
by four-fold and more compared with routine cultu-
res, and demonstrated that the organism is respon-
sible for a large fraction of culture-negative cases 
of septic arthritis and osteomyelitis, which are the 
most common cause of joint and bone infections in 
young children [19, 20]. Since invasive K. kingae di-
Table 1.  Primers and probes used for amplifying rtxA and rtxB in Kingella kingae [21].
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sease occurs from the blood stream infection which 
originated in the upper respiratory tract, therefore, 
a negative pharyngeal PCR tests practically exclu-
des K. kingae as the cause of septic arthritis or os-
teomyelitis [2, 20]. 
Pathogenesis and immunity of Kingella 
kingae
The pathogenesis of invasive K. kingae infection is 
still under investigation and has not been well cha-
racterized. However, K. kingae invasive infections 
almost always develop in children aged between 6 
months and 4 years of age [2, 20]. There are stu-
dies suggest that its invasive potential is induced by 
previous viral infection, which is capable of dama-
ging the oropharyngeal mucosa. Symptoms of viral 
respiratory infection and stomatitis are frequently 
detected in patients with K. kingae disease [2]. A 
recent study of El Houmami et al. [22] reported an 
outbreak of K. kingae infections in association with 
herpangina virus in Marseille, France. The attack 
rate of this infectious outbreak was 23.7% among 
children.
Kingella kingae infections are exceptional in the 
first 6 months of age since the presence of ma-
ternal antibodies provides protection against both 
colonization and disease in early infancy. However, 
older children and adults who have immunosup-
pressing conditions, malignancy or the presence 
of cardiac valve defects may develop K. kingae 
infections [2].
The pathogenesis of invasive K. kingae disea-
se starts with adherence of the bacterium to the 
oropharynx, a process facilitated by specific Virulen-
ce Factor IV pili [2, 20]. The polysaccharide capsule 
of the organism supports it survival in the bloods-
tream of infect young children who have not deve-
loped a mature T-lymphocyte independent immune 
response [20]. 
Kingella kingae strains show wide differences 
in developing invasive infections. Some strains are 
frequently found in asymptomatic carriers, but ra-
rely cause invasive disease [22], while others induce 
blood borne infections and show tropism towards 
skeletal or endocardial tissues [23]. A small num-
ber of K. kingae genotypes cause most observed 
invasive infections worldwide, while others have 
low virulence potential, and rtxA toxin gene se-
quencing analysis demonstrates genetic diversity 
and international clones limited to certain coun-
tries [24]. Therefore, molecular typing of K. kin-
gae strains can identify genomic heterogeneity, 
and allows the elucidation of possible associations 
between the genetic characteristics of the diffe-
rent strains and their tendency to cause invasive 
disease [12].
It has been demonstrated that children aged 
between 6-18 months have the highest rate of K. 
kingae disease and the lowest serum IgG levels 
[25], whereas children aged two years and older 
have a lower incidence of disease and higher IgG 
and IgA levels. These results indicate that carria-
ge or exposure to K. kingae during the first two 
years of a child’s life might be an important factor 
in protection against invasive K. kingae infections 
[25].
Clinical manifestations of Kingella kingae
Children with K. kingae infections are often presen-
ted with mild clinical conditions, and have moderate 
fever, with the exemptions of endocarditis cases, 
invasive K. kingae disease generally develops in 
younger males more than females or other healthy 
children [2, 20].
Kingella kingae bacteremia is frequently transient 
for a short time and blood cultures in children with 
skeletal system infections are usually negative [5].
Most cases of K. kingae bacteremia are detected 
in association with infections of the skeletal, car-
diovascular, respiratory or central nervous systems. 
A number of cases may show maculopapular rash 
similar to those observed in patients with dissemi-
nated meningococcal disease [20]. 
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Skeletal System Infections Kingella kingae
Septic Arthritis
The association between oropharyngeal carriage of 
K. kingae and osteoarticular infection in children 
has been reported in several studies from various 
countries [26-27]. It has been reported that 71% 
of children with osteoarticular infection, carried at 
the same time the identical K. kingae strain in their 
throats, suggesting that children with such infec-
tions should be examined for oropharyngeal infec-
tions [27].
The most common clinical manifestation of in-
vasive K. kingae infections areosteoarticular infec-
tions, and the majority of such infections are found 
in children aged between six 6 and 4 years [27]. A 
recent study by Ceroni et al. [28] found that 82 % 
of the joint or bone aspirates of children aged <4 
years with osteoarticular infection were positive for 
K. kingae.
Arthritis is frequently observed as clinical presen-
tation of K. kingae disease. The disease typically 
involves the large joints of the lower extremities 
and to a less extent, the wrist, elbow, or shoulder 
[29]. However, the limited clinical evidence of septic 
arthritis due to K. kingae can delay rapid diagnosis 
in certain cases, thus leading to delayed treatment 
[2]. About 50% of children with K. kingae arthritis 
may show absence of leukocytosis and a negative 
Gram-stain due to the low presence of bacterial 
cells in the synovial fluids [29].
Osteomyelitis and Spondylodiscitis
Kingella kingae osteomyelitis mostly affects the tu-
bular bones, and may be frequently associated with 
the calcaneus, talus, sternum, and clavicle [30]. Inci-
dence of K. kingae osteomyelitis is frequently more 
insidious than that detected in septic arthritis, and 
most children are diagnosed after weeks of the di-
sease development, and the disease rarely develops 
into a chronic case [30, 31]. Spondylodiscitis due to 
K. kingae infection is also found as osteomyelitis 
and septic arthritis in the older age group of chil-
dren [27]. Additionally, invasion of the epiphysis or 
apophysis of the long bones, is commonly seen in 
K. kingae infections [30].
Endocarditis
Endocarditis is the most serious manifestation of 
K. kingae infection and is observed in at least 20 
% of infected children aged >4 years. The disea-
se causes high fever (>39 °C) more than in those 
who have osteomyelitis or septic arthritis [2, 32]. 
The most frequent serious problem associated with 
K. kingae endocarditis is the emergence of embolic 
complications, which can involve severe neurologi-
cal consequences [32]. Other complications of K. 
kingae endocarditis include cardiogenic shock, val-
vular insufficiency, paravalvula abscesses, and pul-
monary infarction [32, 33].
Other infections 
Other K. kingae infections, such those including the 
lower respiratory tract, the central nervous system, 
the eye and peritoneal cavity are uncommon [2, 34]. 
An outbreak of K. kingae infections associated with 
hand, foot and mouth disease/herpangina virus out-
break has been reported [26]. Meningitis is rarely 
caused by K. kingae, and it is mainly diagnosed in 
adolescents and associated with and antiphospho-
lipid syndrome [35]. 
Epidemiology of Kingella kingae carriage 
Kingella kingae is a human opportunistic pathogen 
that colonizes the oropharynx mucosa of human, 
and its frequently found in children aged between 
6-12 months in the range 8-12% in certain coun-
tries, while colonization decreases in older children 
and reaches nearly nil in adults [2, 20]. The organism 
mostly colonizes the human tonsils and is rarely iso-
lated from the nasopharynx [2, 22]. The colonized 
pharyngeal surfaces are the source of infection that 
transmits K. kingae among young children within 
the family, especially under poor hygienic condi-
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tions [20]. Carriage and transmission are increased 
in daycare centers for children, among whom clus-
ters of invasive K. kingae disease have been repor-
ted, especially associated with upper respiratory vi-
ral infections or stomatitis [20]. Impairment of the 
upper respiratory epithelium, for instance, by viral 
infection, seems to ease bloodstream invasion by 
K. kingae and dissemination to osteoarticular sites, 
body systems and causing endocarditis [5]. 
Healthy adults may also be transient reservoirs 
of the organism, especially by close contacts with 
children between 6 and 48 months of age [2, 20]. 
A new study from New Zealand [19] reported low 
rates of K. kingae colonization in children (2.3%) 
using routine oropharyngeal cultures, whereas by 
applying PCR test a significant higher rate (22.9%) 
of K. kingae colonization have been detected [19]. 
Most older studies reported low carriage rates of 
K. kingae (0.5-12%) using a selective vancomycin-
containing culture [2, 5]. A recent study carried 
among young Jordanian children has not found 
any case among children aged up 5-year (Malak 
A. Khanfar, MSc. Thesis, The Jordan University, 
2019). Also, a new study in Canada has reported 
no prevalence of asymptomatic pharyngeal carria-
ge of K. kingae in young children in Vancouver 
[36].
The carriage rate of K. kingae often decreases in 
older children and adults, suggesting that immu-
ne system response in healthy individuals may have 
contributed toward supper respiratory clearance 
[23, 37].There is only one study reported that the 
carriage stage of K. kingae is 0.8% in adult using 
pharyngeal swabs [20].
There is evidence that genetically specific strains 
of K kingae spread in geographical regions among 
children, suggesting person-to-person transmission 
due to close contacts and in the family [23, 38-
39]. In addition, numerous strains circulating among 
healthy individuals matched strains recovered from 
sites of invasive disease, indicating that certain stra-
ins may persist in the population [38]. A study of 
Yagupsky et al. [20] reported that paired K. kingae 
isolates from the pharynx and bloodstream of 3 chil-
dren were found to be genetically identical, provi-
ding evidence that colonization of the oropharynx 
is proceeding the occurrence of invasive disease. 
Although the carriage rate can be still significantly 
stable throughout the year, where invasive K. kin-
gae infections are most common during late fall and 
early winter, and which coincided with the seasonal 
increase of viral upper respiratory infections [2, 20].
Treatment and prevention of Kingella 
kingae
In recent years, the emergence of bacteria resistant 
to commonly used antibiotics is increasing worldwi-
de, particularly in developing countries. Therefore, 
proper diagnosis and early treatment of patients, 
particularly invasive diseases in children are essential 
to obtain a better outcome and avoid complication 
[26, 40]. 
Kingella kingae is normally susceptible to peni-
cillins and cephalosporin drugs that are empirically 
used for treatment of children with suspected invasi-
ve and skeletal system bacterial infections. However, 
it is recommended to test any available K. kingae 
isolates for β-lactamase production before starting 
treatment [2, 20].
There is still no specific treatment recommended 
for invasive K. kingae disease involving bone and 
joint infection in children [2, 20, 27]. Most K. kingae 
skeletal infections generally recover without com-
plication binding that they are immediately treated 
with proper antibiotics [2, 20]. The duration of an-
tibiotic treatment of children with K. kingae infec-
tions varied according to the body site affected and 
mostly ranged between 1 to 3 weeks [2]. Only pa-
tients with K. kingae endocarditis are treated with 
a high dose of intravenous β-lactam antibiotic plus 
an aminoglycoside drug for 4-7 weeks [20].
Close contacts of the infected children during 
outbreaks of K. kingae infections in day-car centers 
should be treated with oral antibiotics to prevent 
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further transmission by droplet infection. The re-
commended antibiotics included either rifampin or 
a combination of rifampin and amoxicillin for 2-4 
days. This antibiotic prophylaxis reduces K. kingae 
carriage to safe levels [20].
A recent study has reported that a good corre-
lation between MICs and zone diameters was ob-
served for all breakpoints agents for K. kingaewith 
EUCAST (The European Committee on Antimicro-
bial Susceptibility Testing). Presence of β-lactamase 
resistance was found to be associated with resistant 
to trimethoprim, sulfamethoxazole and aminopeni-
cillins, but less resistance was found to tetracycli-
nes. Additionally, no resistance was detected for 
the cephalosporins, carbapenems, and fluoroquino-
lones [41]. 
Conclusions
This review study indicates that K. kingae should be 
considered an important etiological agent in chil-
dren suffering of osteoarticular disease, endocar-
ditis, osteomyelitis and spondylodiscitis infections. 
Pharyngeal colonization is necessary to initiate in-
vasive K. kingae infection. A positive throat swab 
or body fluid specimen using Real-time PCR test 
should be used to confirm its infection and to select 
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